Market Closed -
Euronext Paris
11:35:20 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
20.3
EUR
|
0.00%
|
|
+5.51%
|
+1.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
421.4
|
478.1
|
471.3
|
484.3
|
311
|
207.6
|
207.6
|
-
|
Enterprise Value (EV)
1 |
616.1
|
1,158
|
1,324
|
1,339
|
1,121
|
1,169
|
1,108
|
945.2
|
P/E ratio
|
19.6
x
|
23
x
|
60.5
x
|
20.5
x
|
11.9
x
|
8.78
x
|
9.62
x
|
7.02
x
|
Yield
|
0.87%
|
0.91%
|
0.41%
|
0.85%
|
1.69%
|
2.99%
|
2.12%
|
2.63%
|
Capitalization / Revenue
|
0.78
x
|
0.91
x
|
0.82
x
|
0.7
x
|
0.43
x
|
0.28
x
|
0.25
x
|
0.23
x
|
EV / Revenue
|
1.14
x
|
2.19
x
|
2.31
x
|
1.94
x
|
1.54
x
|
1.59
x
|
1.35
x
|
1.05
x
|
EV / EBITDA
|
11.7
x
|
10.2
x
|
11.4
x
|
9.48
x
|
7.85
x
|
7.85
x
|
8.59
x
|
5.75
x
|
EV / FCF
|
16
x
|
10.4
x
|
9.64
x
|
19.2
x
|
12.5
x
|
13.6
x
|
13.3
x
|
8.86
x
|
FCF Yield
|
6.24%
|
9.63%
|
10.4%
|
5.21%
|
8.02%
|
7.36%
|
7.49%
|
11.3%
|
Price to Book
|
2.14
x
|
2.53
x
|
2.5
x
|
2.23
x
|
-
|
0.74
x
|
0.69
x
|
0.72
x
|
Nbr of stocks (in thousands)
|
9,677
|
9,650
|
9,569
|
9,629
|
10,508
|
10,227
|
10,227
|
-
|
Reference price
2 |
43.55
|
49.55
|
49.25
|
50.30
|
29.60
|
20.30
|
20.30
|
20.30
|
Announcement Date
|
4/3/19
|
4/1/20
|
3/31/21
|
3/30/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
538.8
|
527.9
|
573.9
|
689.5
|
728.2
|
736.1
|
820
|
896.6
|
EBITDA
1 |
52.88
|
113.9
|
116.5
|
141.2
|
142.8
|
148.8
|
129
|
164.4
|
EBIT
1 |
43.97
|
55.12
|
51.38
|
64.81
|
64.31
|
65
|
66
|
75.8
|
Operating Margin
|
8.16%
|
10.44%
|
8.95%
|
9.4%
|
8.83%
|
8.83%
|
8.05%
|
8.45%
|
Earnings before Tax (EBT)
|
35.7
|
36.45
|
18.64
|
36.25
|
-
|
-
|
-
|
-
|
Net income
1 |
21.52
|
20.83
|
7.807
|
23.51
|
25.81
|
23.4
|
22
|
30.47
|
Net margin
|
4%
|
3.95%
|
1.36%
|
3.41%
|
3.54%
|
3.18%
|
2.68%
|
3.4%
|
EPS
2 |
2.226
|
2.158
|
0.8147
|
2.453
|
2.492
|
2.290
|
2.110
|
2.893
|
Free Cash Flow
1 |
38.47
|
111.5
|
137.4
|
69.68
|
89.86
|
85.98
|
83
|
106.6
|
FCF margin
|
7.14%
|
21.12%
|
23.95%
|
10.11%
|
12.34%
|
11.68%
|
10.12%
|
11.89%
|
FCF Conversion (EBITDA)
|
72.74%
|
97.9%
|
117.97%
|
49.33%
|
62.91%
|
57.78%
|
64.34%
|
64.86%
|
FCF Conversion (Net income)
|
178.71%
|
535.36%
|
1,760.45%
|
296.38%
|
348.1%
|
367.42%
|
377.27%
|
350%
|
Dividend per Share
2 |
0.3800
|
0.4500
|
0.2000
|
0.4300
|
0.5000
|
0.6000
|
0.4300
|
0.5333
|
Announcement Date
|
4/3/19
|
4/1/20
|
3/31/21
|
3/30/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2020 S1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
255.5
|
278.3
|
173.6
|
337.3
|
160.1
|
192.1
|
166.4
|
193.5
|
359.9
|
179
|
189.3
|
177
|
186.7
|
363.7
|
176.6
|
198
|
185.3
|
EBITDA
|
28.69
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
22.9
|
21.6
|
-
|
30.9
|
-
|
-
|
-
|
-
|
33.07
|
-
|
-
|
-
|
-
|
32.2
|
-
|
-
|
-
|
Operating Margin
|
8.96%
|
7.76%
|
-
|
9.16%
|
-
|
-
|
-
|
-
|
9.19%
|
-
|
-
|
-
|
-
|
8.85%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/18/19
|
-
|
9/30/21
|
-
|
11/4/21
|
3/30/22
|
6/14/22
|
9/14/22
|
9/14/22
|
11/5/22
|
3/29/23
|
5/4/23
|
9/13/23
|
9/13/23
|
11/7/23
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
195
|
680
|
853
|
854
|
810
|
963
|
900
|
738
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.681
x
|
5.972
x
|
7.324
x
|
6.048
x
|
5.668
x
|
6.472
x
|
6.977
x
|
4.487
x
|
Free Cash Flow
1 |
38.5
|
112
|
137
|
69.7
|
89.9
|
86
|
83
|
107
|
ROE (net income / shareholders' equity)
|
11.4%
|
10.8%
|
4.3%
|
11.5%
|
10.2%
|
7.95%
|
7.3%
|
11%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
20.40
|
19.60
|
19.70
|
22.50
|
-
|
27.30
|
29.50
|
28.20
|
Cash Flow per Share
2 |
5.240
|
11.30
|
15.30
|
8.330
|
-
|
14.30
|
11.80
|
12.70
|
Capex
1 |
9.55
|
6.53
|
9.07
|
10.2
|
12
|
11.5
|
15.4
|
16.9
|
Capex / Sales
|
1.77%
|
1.24%
|
1.58%
|
1.49%
|
1.64%
|
1.57%
|
1.87%
|
1.88%
|
Announcement Date
|
4/3/19
|
4/1/20
|
3/31/21
|
3/30/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Last Close Price
20.3
EUR Average target price
32.5
EUR Spread / Average Target +60.10% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.00% | 222M | | +14.10% | 81.84B | | -30.15% | 70.69B | | +9.37% | 29.03B | | -11.90% | 16.97B | | -0.36% | 16.83B | | -1.12% | 15.28B | | +5.90% | 12.41B | | +35.78% | 12.26B | | -4.20% | 11.86B |
Other Healthcare Facilities & Services
|